What is going on with the children of Fukushima?

Mass thyroid screenings of children at risk of cancer from the 2011 meltdown at Fukushima handed Japanese health officials what they most feared finding—lots of abnormalities. And now the program has set off a firestorm of fear and criticism.

Do the positive findings have anything to do with what happened at the nuclear power plant? Or did the abnormalities originate well before the disaster?

Either way, are the aggressive screenings leading to appropriate care protocols—or just causing undue anxiety?

Science doesn’t have all the answers, but it knows what questions to ask: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.